Sagimet Biosciences, Inc. (SGMT)
10.80
-0.29
(-2.61%)
USD |
NASDAQ |
Sep 21, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Price to Book Value : 2.605 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.675 |
| September 17, 2026 | 2.694 |
| September 16, 2026 | 2.523 |
| September 15, 2026 | 2.523 |
| September 14, 2026 | 2.624 |
| September 11, 2026 | 2.624 |
| September 10, 2026 | 2.668 |
| September 09, 2026 | 2.619 |
| September 08, 2026 | 2.583 |
| September 04, 2026 | 2.639 |
| September 03, 2026 | 2.634 |
| September 02, 2026 | 2.651 |
| September 01, 2026 | 2.532 |
| August 31, 2026 | 2.475 |
| August 28, 2026 | 2.545 |
| August 27, 2026 | 2.593 |
| August 26, 2026 | 2.619 |
| August 25, 2026 | 2.482 |
| August 24, 2026 | 2.463 |
| August 21, 2026 | 2.472 |
| August 20, 2026 | 2.455 |
| August 19, 2026 | 2.552 |
| August 18, 2026 | 2.552 |
| August 17, 2026 | 2.516 |
| August 14, 2026 | 2.545 |
| Date | Value |
|---|---|
| August 13, 2026 | 2.238 |
| August 12, 2026 | 2.265 |
| August 11, 2026 | 2.296 |
| August 10, 2026 | 2.308 |
| August 07, 2026 | 2.185 |
| August 06, 2026 | 2.108 |
| August 05, 2026 | 2.084 |
| August 04, 2026 | 1.927 |
| August 03, 2026 | 1.724 |
| July 31, 2026 | 1.715 |
| July 30, 2026 | 1.763 |
| July 29, 2026 | 1.698 |
| July 28, 2026 | 1.754 |
| July 27, 2026 | 1.797 |
| July 24, 2026 | 1.705 |
| July 23, 2026 | 1.691 |
| July 22, 2026 | 1.700 |
| July 21, 2026 | 1.705 |
| July 20, 2026 | 1.727 |
| July 17, 2026 | 1.886 |
| July 16, 2026 | 1.845 |
| July 15, 2026 | 1.927 |
| July 14, 2026 | 1.870 |
| July 13, 2026 | 1.724 |
| July 10, 2026 | 1.778 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.477 |
| Alnylam Pharmaceuticals, Inc. | 24.12 |
| Anika Therapeutics, Inc. | 2.020 |
| Savara, Inc. | 7.799 |
| Vericel Corp. | 5.466 |
Price to Book Value Related Metrics
| Price | 10.80 |
| Earnings Yield | -11.87% |
| Market Cap | 667.26M |